228 related articles for article (PubMed ID: 665710)
1. Clinical experience with a simple screening test for Cushing's syndrome combining the determination of plasma cortisol circadian rhythm with the overnight dexamethasone suppression test.
Reschini E; Giustina G
Am J Med Sci; 1978; 275(1):33-42. PubMed ID: 665710
[TBL] [Abstract][Full Text] [Related]
2. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.
Montwill J; Igoe D; McKenna TJ
Steroids; 1994 May; 59(5):296-8. PubMed ID: 8073441
[TBL] [Abstract][Full Text] [Related]
3. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.
Newell-Price J; Trainer P; Perry L; Wass J; Grossman A; Besser M
Clin Endocrinol (Oxf); 1995 Nov; 43(5):545-50. PubMed ID: 8548938
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
5. Overnight dexamethasone pre-treatment improves the performance of the lysine-vasopressin test in the diagnosis of Cushing's syndrome.
Contreras P; Araya V
Clin Endocrinol (Oxf); 1996 Jun; 44(6):703-10. PubMed ID: 8759183
[TBL] [Abstract][Full Text] [Related]
6. Cushing's syndrome: a review of diagnostic tests.
Crapo L
Metabolism; 1979 Sep; 28(9):955-77. PubMed ID: 225638
[TBL] [Abstract][Full Text] [Related]
7. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome.
Barrou Z; Guiban D; Maroufi A; Fournier C; Dugué MA; Luton JP; Thomopoulos P
Eur J Endocrinol; 1996 Jan; 134(1):93-6. PubMed ID: 8590965
[TBL] [Abstract][Full Text] [Related]
8. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
Friedman TC
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
[TBL] [Abstract][Full Text] [Related]
9. Single-dose four hour dexamethasone suppression test in normal men and its application for the diagnosis of Cushing's syndrome.
Nishida S; Matsumura S; Horino M; Oyama H; Tenku A
Steroids; 1976 Sep; 28(3):411-21. PubMed ID: 982498
[TBL] [Abstract][Full Text] [Related]
10. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
[TBL] [Abstract][Full Text] [Related]
11. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
12. Cushing's syndrome. Screening methods in hospitalized patients.
Dunlap NE; Grizzle WE; Siegel AL
Arch Pathol Lab Med; 1985 Mar; 109(3):222-9. PubMed ID: 3838451
[TBL] [Abstract][Full Text] [Related]
13. Low-Dose and Standard Overnight and Low Dose-Two Day Dexamethasone Suppression Tests in Patients with Mild and/or Episodic Hypercortisolism.
Mojtahedzadeh M; Shaesteh N; Haykani M; Tran JLA; Mangubat M; Shahinian HK; Nachnani R; Zopey M; Saidian J; Thomas A; Lee ML; McCutcheon IE; Friedman TC
Horm Metab Res; 2018 Jun; 50(6):453-461. PubMed ID: 29719879
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.
Görges R; Knappe G; Gerl H; Ventz M; Stahl F
J Endocrinol Invest; 1999 Apr; 22(4):241-9. PubMed ID: 10342356
[TBL] [Abstract][Full Text] [Related]
15. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
[TBL] [Abstract][Full Text] [Related]
16. Late-night salivary cortisol as a screening test for Cushing's syndrome.
Raff H; Raff JL; Findling JW
J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
[TBL] [Abstract][Full Text] [Related]
17. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
[TBL] [Abstract][Full Text] [Related]
18. Overnight (1 mg) dexamethasone suppression testing reliably distinguishes non-cushingoid obesity from Cushing's syndrome.
Fok AC; Tan KT; Jacob E; Sum CF
Steroids; 1991 Nov; 56(11):549-51. PubMed ID: 1814020
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
[TBL] [Abstract][Full Text] [Related]
20. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
